Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2B | Q13224 | 10/20 | 0.68 |
| ▸ | GRIN1 | Q05586 | 8/20 | 0.68 |
| ▸ | GRIN2D | O15399 | 4/20 | 0.68 |
| ▸ | GRIN3B | O60391 | 4/20 | 0.68 |
| ▸ | GRIN2A | Q12879 | 4/20 | 0.68 |
| ▸ | GRIN2C | Q14957 | 4/20 | 0.68 |
| ▸ | GRIN3A | Q8TCU5 | 4/20 | 0.68 |
| ▸ | NOS2 | P35228 | 1/20 | 0.65 |
| ▸ | HTR3A | P46098 | 2/20 | 0.61 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.61 |
| ▸ | HTR3B | O95264 | 1/20 | 0.61 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.61 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.61 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.59 |
| ▸ | HTR1A | P08908 | 1/20 | 0.59 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.59 |
| ▸ | MAOA | P21397 | 1/20 | 0.59 |
| ▸ | DRD1 | P21728 | 1/20 | 0.59 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.59 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7206541 | 0.98 | GRIN2B (0.65) | GRIN2BGRIN1GRIN2DGRIN3BGRIN2A | |
| Hydrochloric Acid SCHEMBL4629266 | 0.98 | GRIN2B (0.72) | GRIN2BGRIN1GRIN2DGRIN3BGRIN2A | |
| Sulfuric Acid SCHEMBL4014387 | 0.89 | LMNA (0.65) | GRIN2BGRIN1GRIN2DGRIN3BGRIN2A | |
| SCHEMBL1737052 | 0.87 | GRIN1 (0.62) | GRIN2BGRIN1GRIN2DGRIN3BGRIN2A | |
| Amphetamine SCHEMBL28092355 | 0.83 | TAAR1 (0.66) | GRIN2BGRIN1GRIN2DGRIN3BGRIN2A | |
| SCHEMBL10425011 | 0.82 | GRIN2B (0.52) | GRIN2BGRIN1GRIN2DGRIN3BGRIN2A | |
| SCHEMBL1736065 | 0.82 | TAAR1 (0.67) | GRIN2BGRIN1GRIN2DGRIN3BGRIN2A | |
| SCHEMBL1736064 | 0.82 | TAAR1 (0.67) | GRIN2BGRIN1GRIN2DGRIN3BGRIN2A | |
| SCHEMBL5670677 | 0.82 | LTA4H (0.55) | GRIN2BGRIN1GRIN2DGRIN3BGRIN2A | |
| SCHEMBL14291059 | 0.81 | NOS2 (0.96) | GRIN2BGRIN1GRIN2DGRIN3BGRIN2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 925 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025101904-A1 | NOREPINEPHRINE TRANSPORTER-TARGETED PRODRUGS FOR CANCER THERAPY | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2025-05-15 | — | — | WO | claimed |
| CN-119950749-A | Polymer-based macromolecular prodrugs | 费城儿童医院 | 2025-05-09 | — | — | CN | claimed |
| US-20250129016-A1 | PHOTOREDOX METHODS FOR RADIOCYANATION OF ARENES AND USE THEREOF | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2025-04-24 | — | — | US | claimed |
| CN-113557037-B | Radiopharmaceuticals for diagnostic/therapeutic use in nuclear medicine and radioguided medicine | 罗马大学 | 2024-08-09 | — | — | CN | claimed |
| WO-2024139692-A1 | LIGHT-EMITTING APPARATUS AND MANUFACTURING METHOD THEREFOR, AND DISPLAY DEVICE | TCL科技集团股份有限公司 | 2024-07-04 | — | — | WO | claimed |
| CN-118284106-A | Light emitting device, method of manufacturing the same, and display apparatus | TCL科技集团股份有限公司 | 2024-07-02 | — | — | CN | claimed |
| EP-4351650-A1 | COMPOSITION AND METHOD FOR DUAL TARGETING IN TREATMENT OF NEUROENDOCRINE TUMORS | NanoPharmaceuticals LLC (US) | 2024-04-17 | — | — | EP | claimed |
| WO-2024068510-A1 | THERMOPLASTIC MOULDING COMPOSITIONS HAVING AN IMPROVED COLOUR STABILITY-2 | BASF SE (DE) | 2024-04-04 | — | — | WO | claimed |
| WO-2024068508-A1 | THERMOPLASTIC MOULDING COMPOSITIONS HAVING AN IMPROVED COLOUR STABILITY-3 | BASF SE (DE) | 2024-04-04 | — | — | WO | claimed |
| WO-2024068509-A1 | THERMOPLASTIC MOULDING COMPOSITIONS HAVING AN IMPROVED COLOUR STABILITY-1 | BASF SE (DE) | 2024-04-04 | — | — | WO | claimed |
| EP-0624475-B1 | Ink tank, head cartridge and ink jet printing apparatus | CANON KK (JP) | 1999-03-31 | — | — | EP | claimed |
| EP-0449292-B1 | Multilayer printed circuit board and production thereof | HITACHI LTD (JP) | 1997-08-20 | — | — | EP | claimed |
| CN-1083473-A | New imidazolium compounds and pharmaceutical composition thereof | SMITHKLINE BEECHAM CORP (US) | 1994-03-09 | — | — | CN | claimed |
| EP-0283990-B1 | A heat-resistant photosensitive resin composition | TOKYO OHKA KOGYO CO LTD (JP) | 1994-01-26 | — | — | EP | claimed |
| EP-0319751-B1 | UREA-FORMALDEHYDE RESIN, ITS PREPARATION AND USE | Schöllhorn, Wolf-Dietrich (DE) | 1993-02-10 | — | — | EP | claimed |
| EP-0165630-B1 | METHOD OF PREPARING A CHLORINATED, BROMINATED, RADIOBROMINATED, IODINATED AND/OR RADIOIODINATED, AROMATIC OR HETEROAROMATIC COMPOUND, AS WELL AS A KIT FOR PREPARING A DIAGNOSTIC COMPOSITION ON THE BASIS OF THIS COMPOUND | MALLINCKRODT, INC.(a Missouri corporation) (US) | 1989-10-18 | — | — | EP | claimed |
| EP-0283990-A2 | A heat-resistant photosensitive resin composition | TOKYO OHKA KOGYO CO., LTD. (JP) | 1988-09-28 | — | — | EP | claimed |
| EP-0280295-A2 | A heat-resistant photosensitive resin composition | TOKYO OHKA KOGYO CO., LTD. (JP) | 1988-08-31 | — | — | EP | claimed |
| EP-0165630-A2 | Method of preparing a chlorinated, brominated, radiobrominated, iodinated and/or radioiodinated, aromatic or heteroaromatic compound, as well as a kit for preparing a diagnostic composition on the basis of this compound | MALLINCKRODT, INC.(a Missouri corporation) (US) | 1985-12-27 | — | — | EP | claimed |
| US-4341694-A | POLYMERS, 2,6,7-TRIOXA-1-PHOSPHOBICYCLO 2.2.2/OCTANE-4-METHANOL-1-OXIDE | BORG-WARNER CORPORATION (US) | 1982-07-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250129016-A1 | PHOTOREDOX METHODS FOR RADIOCYANATION OF ARENES AND USE THEREOF | RCC2, PPOX, FTO | GRIN2B 2635/4885GRIN1 3299/4885GRIN2D 3934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.